RPL7P11

Across TCGA pan-cancer cohorts, RPL7P11 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL7P11 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL7P11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL7P11 expression acts as an unfavorable survival marker, although some lineages such as THCA and CHOL show a favorable association.

UVM, OV, and ACC are the cancer types where RPL7P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.560	0.945	.001	65	view →
OV	OS	Quartile	II,III,IV	0.260	0.393	.005	54	view →
ACC	DFS	Quartile	All	0.218	0.621	<.001	53	view →
THCA	OS	Median	III,IV	1.000	0.889	<.001	35	view →
PAAD	OS	Tertile	All	0.232	0.485	.021	22	view →
LIHC	OS	Tertile	All	0.684	0.818	.006	21	view →
CHOL	DFS	Median	All	0.773	0.182	.003	20	view →
SKCM	OS	Tertile	All	0.836	0.698	.009	14	view →
THYM	DFS	Tertile	All	1.000	0.656	.010	14	view →
BRCA	OS	Quartile	III,IV	0.967	0.888	.010	12	view →
STAD	OS	Tertile	II,III,IV	0.451	0.632	.030	12	view →
UCS	OS	Tertile	IV	0.756	0.325	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL7P11–UVM (OS)

Open the UVM breakdown →